Considering both Novel Retatrutide and Hyalgan Durolane manage joint discomfort , their approaches of action are distinctly contrasting. the new Retatrutide is a dual medication affecting glucagon-like peptide-1 and the GIP receptor, primarily used for body management , which potentially secondaril